Parabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosedActivity from announced rounds
Develops medicines targeting historically undruggable protein targets in cancer
Provides AI-native due diligence for life sciences dealmaking